Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 24.02.2026 FEX.LN IE00B8X9NW27 1,057,271.00 USD 111,372,184.48 105.339 ...
-
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease....
-
Metropolitan Bank Holding Corp. to Host Investor Day on March 3
NEW YORK--(BUSINESS WIRE)--Metropolitan Bank Holding Corp. (the “Company”) (NYSE: MCB), the holding company for Metropolitan Commercial Bank (the “Bank”), a full-service commercial bank based in New York City, announced that it will host an investor day on Tuesday, March 3, 2026, from 9:30 a.m. to 1:30 p.m. ET. The event will feature presentations and Q&A sessions with Founder, President & CEO, Mark DeFazio, EVP & CFO, Dan Dougherty, and other Bank executives covering commercial len...
-
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life‑changing therapies for people living with gastrointestinal (GI) and rare diseases, today reported its fourth quarter and full‑year 2025 results and recent business performance. “In 2025, LINZESS delivered 11% EUTRx demand growth year-over-year, continuing to strengthen its position as the prescription market leader for the treatment of IBS-C and CIC, surpassing 5.7...
-
NexMetro Introduces Private Equity Build-To-Rent Investment Fund for 2026
PHOENIX--(BUSINESS WIRE)--NexMetro's Direct Access Fund offers portfolio of BTR projects in high-growth U.S. markets....
-
Valuedynamx Appoints Eileen Peacock, SVP, General Manager, Valuedynamx U.S. to Lead on Market Expansion
BOSTON--(BUSINESS WIRE)--Valuedynamx, a Collinson Company and leading provider of purchase rewards, today announced that Eileen Peacock has joined as SVP, General Manager, Valuedynamx U.S. With more than 30 years of experience spanning financial services, travel, retail and loyalty, Peacock brings deep sector expertise aligned with Valuedynamx’s strategic priorities. Eileen will lead business development and client services operations to strengthen Valuedynamx's partnerships with airlines, fina...
-
Marsh Appoints Peter Harrison to Its Board of Directors
NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today appointed Peter Harrison as a director, effective immediately. The Company’s Board now consists of 13 directors. Commenting on Mr. Harrison’s appointment, H. Edward Hanway, Chair of the Company’s Board of Directors, said, “We are pleased to welcome Peter as a director. We are committed to ensuring the right blend of skills and experience on ou...
-
BKV Corporation Reports Fourth Quarter and Full Year 2025 Results
DENVER--(BUSINESS WIRE)--BKV Corporation (NYSE: BKV) (“BKV” or the “Company”), today reported financial and operational results for the fourth quarter and full year 2025, as well as provided guidance for the first quarter and full year 2026. Fourth Quarter 2025 Highlights Net income attributable to BKV of $70.4 million, or $0.75 per diluted share Adjusted Net Income of $26.6 million, or $0.29 per diluted share Combined Adjusted EBITDAX attributable to BKV of $109.3 million (includes implied 50%...
-
Charles River Laboratories Provides Update on Planned Divestitures
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Provides Update on Planned Divestitures...
-
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026
DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter and year ended Dec. 31, 2025 and provided financial expectations for 2026. To view the detailed fourth quarter and full year 2025 earnings press release and presentation please visit the company’s investor relations website at https://investor.alkermes.com. Alkermes will host a conference call and webcast presentation at 8:00 a.m. EST (1:00 p.m. GMT) today, to discuss these financial results an...